Though the relationship between vitamin D and breast cancer remains unclear, a growing
body of evidence suggests that vitamin D may modestly reduce risk. A large number of in …

Abstract The tea polyphenol (−)-epigallocatechin-3-gallate (EGCG) has been reported to act
as a cancer preventive agent through folate pathway inhibition in experimental studies. We …

Elevated homocysteine levels are a risk factor for breast cancer, although the mechanism
underlying this effect is unknown. Genome‐wide association studies were used to …

Published data on the association between methylenetetrahydrofolate reductase (MTHFR)
gene polymorphisms and breast cancer risk are inconclusive. We investigated the …

Background: Epidemiological studies evaluating the association of vitamin B 6, vitamin B 12
and methionine with breast cancer risk have produced inconsistent results. Methods …

Background: Folate deficiency is implicated in cancer development. Single nucleotide
polymorphisms in the methylenetetrahydrofolate reductase (MTHFR) gene can modulate the …

There are substantial data on breast tumorigenesis in animals that suggest that diet may be
an important factor in human breast cancer etiology. The promotional effects of dietary fat …

Objective The 677 C> T and 1298 A> C polymorphisms of methylenetetrahydrofolate
reductase (MTHFR) gene have been widely reported and considered to have a significant …

Recent evidence has suggested a role for vitamin D in breast cancer prevention and
survival. Studies have reported an inverse relation between vitamin D intake and the risk of …

Objectives: Increased breast cancer risk has been observed with both low folate status and a
functional polymorphism in methylenetetrahydrofolate reductase (MTHFR 677C→ T) …